Dorian LPG
LPG
Hutchmed (China)
HCM
Collegium Pharmaceutical
COLL
4
Halozyme Therapeutics
HALO
5
eBay
EBAY
US Stock MarketDetailed Quotes
CRSP CRISPR Therapeutics
- 38.360
- +4.100+11.97%
Trading Apr 11 14:40 ET
3.29BMarket Cap-8.84P/E (TTM)
38.865High34.440Low2.45MVolume34.440Open34.260Pre Close90.97MTurnover2.87%Turnover RatioLossP/E (Static)85.77MShares67.88052wk High1.70P/B3.27BFloat Cap30.04052wk Low--Dividend TTM85.37MShs Float220.200Historical High--Div YieldTTM12.92%Amplitude11.630Historical Low37.082Avg Price1Lot Size
CRISPR Therapeutics Key Stats
EPS
According to the latest financial report of CRISPR Therapeutics, the latest earnings per share (TTM) for the company is -0.44. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about CRISPR Therapeutics's free cash flow? The latest report shows it as -50.29M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of CRISPR Therapeutics shows that the company's current ratio is 22.07, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of CRISPR Therapeutics, the quick ratio is 21.97, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ROE
Want to learn more about the financial health of CRISPR Therapeutics? The latest ROE figure is -1.93%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of CRISPR Therapeutics, the total asset return on investment (ROA) is -1.66%.
Currency: USD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check CRISPR Therapeutics's latest financial report to see how their gross margin is doing - currently at 100.00%.
Currency: USD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of CRISPR Therapeutics, the net profit margin is -104.54%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Market Insights
Discussing
Chinese stock earnings surge: Will profit sustain the rally?
1. Which sectors are likely to be market highlights this season? 2. With the government's emphasis on technological innovation and sustaina
Moomoo News Global
Mar 4 23:26
China's Two Sessions: Key Takeaways on Stock Price Movements Before and After the Meetings